Insulin and related growth factors such as IGF-1 and IGF-2 have recently been demonstrated to be important molecules in the regulation of cellular proliferation and in the development of the central nervous system (CNS). At the cellular level, for example, insulin promotes neuritic sprouting that is believed to be essential to initiate and maintain cellular contacts required for many physiologic functions including learning. Therefore, there is a need to better understand the molecular effects of ethanol on the IGF-1/insulin mediated signal transduction cascade as it relates to growth and development of the CNS. In order to accomplish these goals, it will be necessary to produce and characterize monoclonal and polyclonal antibody reagents to various structural and functional domains of the IRS-1 molecule as well as provide recombinant eukaryotic and prokaryotic proteins to be used in immunoprecipitation and kinase assays particularly in cellular extracts that have been prepared from tissues or neuronal cells exposed to ethanol. In this regard, our plans are as follows: 1) Develop cDNA expression constructs that contain various functional domains of the IRS-1 protein. 2) Characterize the functional properties of expressed recombinant proteins within transfected neuronal cells under the influence of IGF-1 and insulin stimulation 3) Produce monoclonal antibodies to functional domains and tyrosyl phosphorylation motifs of the IRS-1 molecule and characterize such antibodies with respect to: affinity constants, epitope specificity, immunoprecipitation and Western blot analysis, binding to the functional domains of the IRS-1 molecule, antiphosphotyrosine specificity and tissue and cellular distribution within cells and different regions of the human central nervous system. It is anticipated that the large library of monoclonal antibodies prepared against the various domains of the IRS-1 molecule will be made widely available to NIAAA funded investigators for cellular and molecular studies of IGF-1 and insulin mediated signal transduction processes in cells of CNS or other origin under the influence of acute and chronic ethanol exposure.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Project (R01)
Project #
7R01AA011431-04
Application #
6051125
Study Section
Special Emphasis Panel (SRCA)
Project Start
1996-09-30
Project End
2001-08-31
Budget Start
1999-05-01
Budget End
1999-08-31
Support Year
4
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Rhode Island Hospital (Providence, RI)
Department
Type
DUNS #
161202122
City
Providence
State
RI
Country
United States
Zip Code
02903
Mandelbaum, David E; Arsenault, Amanda; Stonestreet, Barbara S et al. (2018) Neuroinflammation-Related Encephalopathy in an Infant Born Preterm Following Exposure to Maternal Diabetic Ketoacidosis. J Pediatr 197:286-291.e2
de la Monte, Suzanne M; Tong, Ming; Wands, Jack R (2018) The 20-Year Voyage Aboard the Journal of Alzheimer's Disease: Docking at 'Type 3 Diabetes', Environmental/Exposure Factors, Pathogenic Mechanisms, and Potential Treatments. J Alzheimers Dis 62:1381-1390
Tong, Ming; Leão, Raiane; Vimbela, Gina V et al. (2017) Altered temporal lobe white matter lipid ion profiles in an experimental model of sporadic Alzheimer's disease. Mol Cell Neurosci 82:23-34
Yalcin, Emine B; McLean, Tory; Tong, Ming et al. (2017) Progressive white matter atrophy with altered lipid profiles is partially reversed by short-term abstinence in an experimental model of alcohol-related neurodegeneration. Alcohol 65:51-62
de la Monte, Suzanne M; Tong, Ming; Schiano, Irio et al. (2017) Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease. J Alzheimers Dis 55:849-864
de la Monte, Suzanne M (2017) Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease. Drugs 77:47-65
Tong, Ming; Deochand, Chetram; Didsbury, John et al. (2016) T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease. J Alzheimers Dis 51:123-38
Tong, Ming; Dominguez, Cesar; Didsbury, John et al. (2016) Targeting Alzheimer's Disease Neuro-Metabolic Dysfunction with a Small Molecule Nuclear Receptor Agonist (T3D-959) Reverses Disease Pathologies. J Alzheimers Dis Parkinsonism 6:
Yalcin, Emine; de la Monte, Suzanne (2016) Tobacco nitrosamines as culprits in disease: mechanisms reviewed. J Physiol Biochem 72:107-20
Andreani, Tomas; Tong, Ming; Gundogan, Fusun et al. (2016) Differential Effects of 3rd Trimester-Equivalent Binge Ethanol and Tobacco-Specific Nitrosamine Ketone Exposures on Brain Insulin Signaling in Adolescence. J Diabetes Relat Disord 1:

Showing the most recent 10 out of 89 publications